Call Help Lines
954-785-1121

>>> UPGRADE YOUR MEMBERSHIP NOW AND GET IT ALL - CLICK HERE
CANSLIM.net Stock Bulletins - NMHC
02/16/04   CANSLIM.net
 

CANSLIM.net STOCK BULLETIN
"A Vital Service for the CANSLIM Investor" 

Sunday, February 16th, 2004 | 5:58 PM

 

 


National Medical Health Card System Inc (NMHC $25.95) is an established leader in managing prescription drug programs for HMOs, employers, local governments, union groups and third party administrators.

According to the company, NMHCRX, headquartered in Port Washington, NY with service centers in Latham, NY and Little Rock, AR has been raising the bar by striving for innovation in technology, and providing unmatched clinical and service experience for over two decades. The company's efforts have proven successful as it ranked 27 on Fortune magazine's 2003 "America's 100 Fastest Growing Companies" list.

CANSLIM related high points for this leading company of IBD's highly ranked Medical/Dental-Service group include:

  • Decent Current quarterly earnings comparisons (see numbers below)

  • Nice Annual earning history with steady EPS increases year to year since 2001 and estimated increases in coming years.

  • New sponsors (customers), as well as growth in existing sponsors during the past quarter. All time New price highs.

  • Small supply of Shares outstanding (7.65 mil) means stock can more easily move. (up or down)

  • A Leading company as the stock is currently in IBD's list of " Top 5 Companies in the Medical/Dental-Services Group".

  • With Institutions owning 4% means mutual fund managers are aware of NMHC and there is room for more possibly to step in.

Technically the chart for NMHC makes for an interesting case as the stock quickly doubled and became very extended in about a month's time (10/30 - 12/02) then consolidated near its 50 DMA. Another important aspect to recognize is the volume during that move and through today is overall more intense compared to before its run started on 10/31. The stand out trading action of that day coincides with a pre-market press release, titled "National Medical Health Card Announces Major Initiative to Accelerate Growth" the company issued that morning.

The stock has continually run into resistance near the $26-$27 range. On 02/10 while attempting to follow up on a just previous good up day with a big volume breakout, it was turned back at $27.25. That day it actually wound up closing the session with a substantial loss but importantly held above a fairly substantial upward trend line. This action leads to the possibility that the more skittish investors were shaken out and the current investors may be more willing to hold.

Currently the stock sits near all time highs with the last two session with light volume may be an indication that there are not many willing sellers at this point. If one adds ten cents to NMHC’s most recent significant high of $26.00 on 12/03/03, they would arrive at a pivot of $26.10. As always a break through the pivot point on heavy volume would trigger a technical buy signal and the patient investor should wait to see this possibly occur before buying.

A key concern is that National only trades an average of around 56,500 shares on a typical trading day. This may make it difficult for institutional investors to avoid disrupting the share price when making any meaningful accumulation or distribution of ownership interest.  Company management, it is worth noting, owns a 48% interest, which certainly keeps them motivated to maintain and maximize shareholder value.  Due to liquidity concerns, investors may still want to tread very carefully.  Consider taking a smaller than normal position and possibly adding to it assuming more reassuring technical action.  Watch the stock very closely, as the action on 10/31 proves how extremely volatile this stock can be.  Also study its weekly chart, which shows that the stock has already enjoyed a substantial run.  Thus, the proper sell discipline is advised as always, which means always limiting losses at 7-8%

 

Prior 4 Quarterly earnings % Changes:

Mar '03 vs '02 +57% June '03 vs '02 +31% Sep '03 vs '02 +12% Dec '03 vs '02 +25%
Shares Outstanding: 7.65 Million 50-Day Avg Vol: 56,500
Pivot Point: (.10 above high on 11/03/03) $26.10 Max Buy Price: $27.40

More Info: 5-year Chart from BigCharts.com

Additional Resources...  
Financials, StockTalk, News, Chart , SEC, Zacks Reports

 

This is a new service provided by CANSLIM.net News to all current paying subscribers of CANSLIM.net News and CANSLIM.net Stock Alert Reports. We are interested in hearing your feedback. Direct your questions or comments to jamest@canslim.net.  More information on any issues is available by request, just call 1-800-965-8307.  Information contained herein is believed accurate but not warranted.  CANSLIM.net is not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities.

© Copyright 2004, http://www.canslim.net/. All rights reserved and protected by the copyright laws of the United States and Canada and by international treaties. CAN SLIM (written here as "CANSLIM" or "Canslim:) is a registered trademark of William O'Neil + Co.  CANSLIM.net is not owned nor affiliated with William O'Neil + Co. or any of their subsidiaries including The Investor's Business Daily newspaper.

About : Newsdesk

You can contact Newsdesk at kengruneisen@gmail.com

 
The information and writings made avaialable by individuals that successfully passed the  CAN SLIM® Masters Program are their own.  Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties. 


Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us